Koichi Tatsuta

Excessive ADAM17 activation occurs in uremic patients and may contribute to their immunocompromised status

S. Negi, T. Shigematsu, K. Kawakami, 2020, Immunity, inflammation and disease.

Need for education on the differential diagnosis between chronic glomerulonephritis and nephrosclerosis, and treatment of both conditions to reduce the number of patients requiring hemodialysis in Wakayama.

T. Sakaguchi, S. Negi, T. Shigematsu, 2012, Internal medicine.

Blood purification therapy for patients with connective tissue diseases

S. Negi, T. Shigematsu, F. Furukawa, 2016 .

Active vitamin D and vitamin D analogs stimulate fibroblast growth factor 23 production in osteocyte-like cells via the vitamin D receptor.

S. Negi, T. Shigematsu, K. Kawakami, 2020, Journal of pharmaceutical and biomedical analysis.

Expression and localization of fibroblast growth factor (FGF)23 and Klotho in the spleen: its physiological and functional implications

S. Negi, T. Shigematsu, Masaki Ohya, 2016, Growth factors.

Acute kidney injury: Epidemiology, outcomes, complications, and therapeutic strategies

S. Negi, T. Shigematsu, Masaki Ohya, 2018, Seminars in dialysis.

Effects of Cyclophosphamide Pulse Therapy on the Clinical and Histopathological Findings, Particularly Crescent Formation, in a Patient with Adult-onset Steroid-refractory Henoch-Schönlein Purpura Nephritis.

T. Sakaguchi, S. Negi, T. Shigematsu, 2015, Internal medicine.

The management of hyperphosphatemia by lanthanum carbonate in chronic kidney disease patients

T. Sakaguchi, S. Negi, T. Shigematsu, 2012, International journal of nephrology and renovascular disease.